EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin

PHASE4CompletedINTERVENTIONAL
Enrollment

544

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
Osteoarticular Infection
Interventions
DRUG

Rifampicin

Patients will be randomly assigned to low dosage (10 mg/kg/j) rifampicin group or high dosage (20 mg/kg/j) rifampicin group. Rifampicin treatment will be prescribed in association with another antibiotic chosen by investigator according to the antibiogram results. Association with fluoroquinolones is the first choice combination, if it is possible. The global antibiotic treatment duration depends on the investigator's choice.

Trial Locations (16)

14033

Caen university hospital, Caen

22027

Saint-Brieuc hospital, Saint-Brieuc

29609

Brest university hospital, Brest

33076

Bordeaux university hospital, Bordeaux

35000

Rennes university hospital, Rennes

35059

Toulouse university hospital, Toulouse

35400

Saint-Malo hospital, St-Malo

37044

Tours university hospital, Tours

44093

Nantes university hospital, Nantes

49933

Angers university hospital, Angers

56017

Vannes hospital, Vannes

56322

Lorient hospital, Lorient

64046

Pau hospital, Pau

69100

Clinique du Parc et Hôpital Jean Mermoz, Lyon

85925

La Roche sur Yon hospital, La Roche-sur-Yon

86000

Poitiers university hospital, Poitiers

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT02599493 - EVRIOS : Comparative Evaluation of Low Versus High Doses of Rifampicin | Biotech Hunter | Biotech Hunter